Scott Rocklage Keen on Using Science to Solve Tomorrow’s Medical Needs

Scott M. Rocklage, Ph.D., is one of 5AM Ventures’ Managing Partners. He has been in the healthcare management industry for over 30 years. His leadership style paired with a strategic responsibility approach has led to significant successes throughout his career. Among his achievements include the FDA approval of three New Drugs Applications in the United States which are, Cubicin, Omniscan, and Teslascan.


Scott Rocklage’s Educational Background


Dr. Rocklage attended the University of California where he attained his Bachelor’s Degree in Chemistry. He went on to further his education at the Michigan Institute of Technology where he got his Ph.D. in Chemistry. During this time, he conducted his research with Nobel Laureate in Chemistry for the year 2005, Richard R. Schrock. Mr. Rocklage is also a co-inventor and inventor of more than 30 United States patents and retains over 100 peer-reviewed publications.


Work Experience


Rocklage served as the Chief Executive Officer of Cubist Pharmaceuticals Inc. between July 1994 and March 2001. Also, he served as the CEO and President of Nycomed Salutar, Inc. from 1990 to 1994. At Salutar and Catalyca Pharmaceuticals, he oversaw various R&D projects. Rocklage has been the Board Chairman at Cidara Theraputics, Inc. since 2013. He has also remained the Chairman of Novira Therapeutics, Inc. since his appointment in August 2012.


Scott Rocklage’s other positions include Board Chair at Rennovia Inc. and a board membership position in the Whitehead Institute’s Associate Board. Furthermore, he has served in an Executive position at Semprus and Miikana Theraputics Inc. Rocklage has held several other director positions at EPIRUS Biopharmaceuticals, Inc.; Relypsa, Inc.; Achaogen, Inc.; Pulmatrix, Inc.; and MDS Proteomics.


About 5AM Ventures


Dr. Scott Rocklage became part of the 5AM Venture team in 2003 as a Partner and later rose to Managing Partner in 2004. 5AM Ventures is a pace setter capital firm that is focused on building the next era of life science companies. The company is confident that this will help deliver tangible returns to investors. It invests in companies striving to solve healthcare problems through cutting-edge breakthroughs in science and medicine.


All 5AM professionals are experienced in finance as well as medical and legal operations. The team employs a hands-on approach towards company building. Other 5AM functions include recruiting management professionals, setting business strategies, fundraising, and business development.

Leave a Comment

Your email address will not be published. Required fields are marked *